These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1683615

  • 1. Beta-blockade in the primary prevention of coronary heart disease in hypertensive patients. Review of present evidence.
    Wikstrand J, Berglund G, Tuomilehto J.
    Circulation; 1991 Dec; 84(6 Suppl):VI93-100. PubMed ID: 1683615
    [Abstract] [Full Text] [Related]

  • 2. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
    Wikstrand J.
    J Cardiovasc Pharmacol; 1990 Dec; 16 Suppl 5():S64-75. PubMed ID: 11527139
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B, Devereux RB, Kjeldsen SE, Lyle PA, Zhang Z, Edelman JM.
    Blood Press; 2007 Dec; 16(1):6-12. PubMed ID: 17453746
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A meta-analysis of mortality and coronary prevention in hypertensive patients treated with beta-receptor blockers.
    Shinton RA, Beevers DG.
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():31-4. PubMed ID: 1973461
    [Abstract] [Full Text] [Related]

  • 10. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S, Bakir SE.
    Drugs; 2000 Jun; 59 Spec No 2():25-37. PubMed ID: 11002856
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.
    Blood Press; 2004 Jun; 13(3):137-41. PubMed ID: 15223721
    [Abstract] [Full Text] [Related]

  • 12. Prevention of sudden death using beta-blockers. Review of possible contributory actions.
    Olsson G, Rydén L.
    Circulation; 1991 Dec; 84(6 Suppl):VI33-7. PubMed ID: 1683608
    [Abstract] [Full Text] [Related]

  • 13. Implications of the primary prevention trials against coronary heart disease.
    Kannel WB.
    J Hypertens Suppl; 1990 Dec; 8(7):S245-50. PubMed ID: 1982770
    [Abstract] [Full Text] [Related]

  • 14. Beta blockade and intermittent claudication.
    Lepäntalo M.
    Acta Med Scand Suppl; 1985 Dec; 700():1-48. PubMed ID: 2865873
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term safety of antihypertensive therapy.
    Grossman E, Messerli FH.
    Prog Cardiovasc Dis; 2006 Dec; 49(1):16-25. PubMed ID: 16867847
    [Abstract] [Full Text] [Related]

  • 17. Are we misunderstanding beta-blockers.
    Cruickshank JM.
    Int J Cardiol; 2007 Aug 09; 120(1):10-27. PubMed ID: 17433471
    [Abstract] [Full Text] [Related]

  • 18. Coronary artery disease can be prevented by antihypertensive therapy: experiences from the MAPHY Study.
    Tuomilehto J, Wikstrand J, Warnold I, Olsson G, Elmfeldt D, Berglund G.
    J Cardiovasc Pharmacol; 1990 Aug 09; 16 Suppl 7():S75-6. PubMed ID: 1708032
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G.
    Anesth Analg; 2008 Apr 09; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.